简体中文 | 繁體中文 | English

Press Releases

2021-12-13 09:55 Airline Passenger Capacity is Projected to Grow at 47% in 2022
2021-12-13 09:49 SOPA 2022 Journalism Awards Open for Entries; Deadline 17 Feb
2021-12-13 09:36 Civil Society Organizations and Over 100 Governments Push for Reforms against Authoritarianism, Corruption, and Closing Civic Space
2021-12-13 09:31 First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
2021-12-13 09:22 Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors
2021-12-13 09:18 Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices
2021-12-10 18:57 Moody’s Recognized with CDP’s ‘A’ Score on Climate Action for Second Consecutive Year
2021-12-10 18:56 Diligent Releases First Automated Health Check, Helping Companies Achieve Superior Confidence in Their Corporate Record
2021-12-10 18:54 Expedera Raises $18M Series A Funding to Advance Its Deep Learning Accelerator IP
2021-12-10 18:52 Toshiba Unveils New 18TB MN09 Series NAS Hard Disk Drives
2021-12-10 18:49 New Global Survey Finds Consumers Are Becoming More Selective About Where, When and How They Share Information with Brands
2021-12-10 18:45 NetApp Customers Say Hybrid Cloud is the Future of Enterprise IT in New Global Survey
2021-12-10 16:05 DXC Technology Enables Copa Airlines’ Transformation by Modernizing and Migrating Passenger Service System with Cloud Right™ Approach
2021-12-10 15:06 Accel-KKR Backs Entersekt, A Leader in Frictionless Authentication Solutions
2021-12-10 14:33 Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
2021-12-10 14:31 Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
2021-12-10 14:26 Nam Tai Property Announces the Appointment of Yu Chunhua as Executive Director, Legal Representative and Signatory of Key Subsidiary
2021-12-10 14:23 AVI Launches Public Website Highlighting MOL's Exploitation of Daibiru
2021-12-10 13:30 NielsenIQ Rises to the Omnichannel Measurement Challenge
2021-12-10 12:24 LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin

Business Wire Weibo

Industries

Latest Releases